# Simarato

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/simarato

- Industry: Medical Devices & Equipment
- Headquarters: Paris, France
- Website: www.biomodex.com
- Total disclosed funding: $13M
- Latest round: Series B (Jun 5, 2018)
- Investors on record: 6

## About

Simarato SAS is a Paris-based company that specializes in advanced 3D printing solutions aimed at enhancing medical training and patient-specific surgical rehearsals through biorealistic haptic simulators.Founded in 2015 and headquartered in Paris, France, Simarato SAS develops advanced training technologies for medical professionals. The company experienced a pivotal moment in June 2018 when it raised EUR 8.17 mn in Series B funding led by Idinvest Partners. The company operates without known subsidiaries or parent companies, and it has successfully completed two funding rounds to date. The CEO is Ziad R, who has not been previously mentioned as a founder of another company.BIOMODEX® specializes in providing advanced 3D printing solutions that facilitate patient-specific rehearsal and training for physicians. Their core offerings are biorealistic haptic simulators replicating various medical scenarios, assisting in training for neurovascular procedures, ischemic stroke interventions, aortic arch catheterism, and cardiovascular training. The company serves healthcare institutions and medical training facilities primarily in the Americas and EMEA regions, delivering sophisticated tools to enhance physician skills and patient safety.In the most recent financial year of 2022, Simarato SAS reported revenue of EUR 671,644 with an EBITDA loss amounting to EUR 2,327,069.3.Following the EUR 8.17 mn funding raised in June 2018, Simarato SAS is focusing on the development of new products designed to enhance medical training and patient care. The company plans to expand into additional markets, including increased penetration in both the Americas and EMEA regions within the next few years. Recent funding will support these initiatives, enhancing product development and market outreach efforts.

## Funding rounds

- Series B, Jun 5, 2018, $9.6M — Idinvest Partners, LBO France, Innovation Capital, Inserm Transfert Initiative, InnovAllianz
- Series A, Jul 22, 2016, $3M — Kima Ventures, Innovation Capital, Inserm Transfert Initiative

## Investors

- Kima Ventures (https://capitalatlas.ai/funds/kima-ventures) — Series A
- Innovation Capital — Series A, Series B
- Inserm Transfert Initiative (https://capitalatlas.ai/funds/inserm-transfert-initiative) — Series A, Series B
- Idinvest Partners (https://capitalatlas.ai/funds/idinvest-partners) — Series B
- LBO France (https://capitalatlas.ai/funds/lbo-france) — Series B
- InnovAllianz — Series B